Capitalized Expenditures. Make Capitalized Expenditures, in the aggregate in any fiscal year of Borrower, in excess of 175% of the amount approved by Borrower’s Board of Directors and set forth in the most recently approved operating plan delivered to Bank in accordance with Section 6.2(iii) of this Agreement.
Appears in 4 contracts
Samples: Loan and Security Agreement, Loan and Security Agreement (Kaleido Biosciences, Inc.), Loan and Security Agreement (Rubius Therapeutics, Inc.)
Capitalized Expenditures. Make Capitalized Expenditures, in the aggregate in any fiscal year of Borrower, Expenditures in excess of 175% of the amount approved by Borrower’s Board of Directors and set forth in the most recently approved operating plan delivered to Bank in accordance with Section 6.2(iii) of this Agreementhereof.
Appears in 3 contracts
Samples: Loan and Security Agreement (Evelo Biosciences, Inc.), Loan and Security Agreement (Evelo Biosciences, Inc.), Loan and Security Agreement (Evelo Biosciences, Inc.)
Capitalized Expenditures. Make Capitalized Expenditures, in the aggregate in any fiscal year of Borrower, Expenditures in excess of 175% of the amount approved by Borrower’s Board board of Directors directors and set forth in the most recently approved operating plan delivered to Bank in accordance with Section 6.2(iii) of this AgreementBank.
Appears in 1 contract
Samples: Loan and Security Agreement (Omega Therapeutics, Inc.)
